EYEGATE PHARMACEUTICALS INC - COM (EYEG)

CUSIP: 30233M107

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
360,429
Share change
-10,819
Total reported value
$987,000
Price per share
$2.73
Number of holders
6
Value change
-$31,356
Number of buys
2
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 30233M107?
CUSIP 30233M107 identifies EYEG - EYEGATE PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EYEGATE PHARMACEUTICALS INC - COM (EYEG) as of Q4 2015

As of 31 Dec 2015, EYEGATE PHARMACEUTICALS INC - COM (EYEG) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 360,429 shares. The largest 6 holders included SABBY MANAGEMENT, LLC, AWM Investment Company, Inc., VANGUARD GROUP INC, Vantage Investment Advisors, LLC, MORGAN STANLEY, and UBS Group AG. This page lists 6 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.